Can fluoxetine (selective serotonin reuptake inhibitor) cause dysuria (painful urination)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Fluoxetine and Dysuria: A Recognized Adverse Effect

Yes, fluoxetine can cause dysuria (painful urination) as a rare but documented adverse effect related to its serotonergic properties that affect urinary tract function.

Mechanism and Evidence

Fluoxetine, a selective serotonin reuptake inhibitor (SSRI), can affect urinary function through several mechanisms:

  1. Serotonergic Effects on Urinary Function:

    • Serotonin plays a role in regulating bladder function and micturition
    • Fluoxetine's enhancement of serotonergic transmission can alter normal urinary tract function
  2. Documented Cases:

    • Recent case reports have documented urinary retention associated with fluoxetine use 1
    • A 2022 case report described a 15-year-old girl who developed chronic urinary retention during fluoxetine monotherapy, which resolved after discontinuation of the medication 1
  3. Pharmacological Interactions:

    • Fluoxetine's pharmacokinetic properties, particularly its inhibition of CYP2D6, may contribute to urinary side effects 2
    • When combined with other medications, the risk may increase, as seen in a case of urinary retention after fluoxetine-risperidone combination 3

Risk Factors and Presentation

Patients at higher risk for fluoxetine-related dysuria include:

  • Those with pre-existing genitourinary conditions
  • Older adults (who are more susceptible to anticholinergic effects)
  • Patients taking multiple medications that affect urinary function
  • Those on higher doses of fluoxetine

Symptoms may present as:

  • Painful urination (dysuria)
  • Difficulty initiating urination
  • Sensation of incomplete bladder emptying
  • In severe cases, urinary retention requiring intervention

Management Approach

When dysuria occurs in a patient taking fluoxetine:

  1. Assess Causality:

    • Rule out other common causes of dysuria (UTI, prostatitis, etc.)
    • Consider timing of symptom onset in relation to fluoxetine initiation or dose changes
  2. Intervention Options:

    • Dose Reduction: Consider lowering the dose if clinically appropriate
    • Medication Switch: If symptoms persist, consider switching to another antidepressant with lower incidence of urinary side effects
    • Discontinuation: In severe cases, discontinuation of fluoxetine may be necessary, as demonstrated in case reports where symptoms resolved after stopping the medication 1
  3. Monitoring:

    • Monitor for resolution of symptoms after intervention
    • Watch for signs of urinary retention, which can be a more serious complication

Clinical Considerations

  • The American Family Physician notes that SSRIs, including fluoxetine, can cause various adverse effects, though urinary symptoms are not among the most common 2
  • When selecting antidepressants for older patients who may be more susceptible to urinary side effects, citalopram, escitalopram, sertraline, mirtazapine, venlafaxine, and bupropion are generally preferred over fluoxetine 2
  • Fluoxetine is metabolized by CYP2D6, and genetic variations in this enzyme may affect drug metabolism and potentially increase the risk of adverse effects 2

Conclusion

While not among the most commonly reported side effects, dysuria can occur with fluoxetine use. The evidence from case reports demonstrates a clear temporal relationship between fluoxetine administration and urinary symptoms, with resolution upon discontinuation. Clinicians should be aware of this potential adverse effect when prescribing fluoxetine and monitor patients accordingly, especially those with pre-existing urinary tract conditions.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Urinary retention caused after fluoxetine-risperidone combination.

Journal of psychopharmacology (Oxford, England), 2001

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.